Back
Vir Biotechnology 10K Form
Buy
65
VIR
Vir Biotechnology
Last Price:
10.39
Seasonality Move:
6.32%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive VIR News And Ratings
See the #1 stock for the next 7 days that we like better than VIR
VIR Financial Statistics
Sales & Book Value
| Annual Sales: | $39.49M |
|---|---|
| Cash Flow: | $-109.46M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $11.80 |
| Price / Book: | 0.88 |
Profitability
| EPS (TTM): | -4.59000 |
|---|---|
| Net Income (TTM): | $-615.06M |
| Gross Margin: | $36.73M |
| Return on Equity: | -33.71% |
| Return on Assets: | -26.34% |
Vir Biotechnology Earnings Forecast
Key Vir Biotechnology Financial Ratios
- The Gross Profit Margin over the past 5 years for VIR is 93.00%.
- The Selling, General & Administrative Expenses for VIR have been equal to 450.83% of Gross Profit Margin.
- The Research & Development expenses have been 1,493.06% of Revenue.
- The Net Earning history of VIR is -1,557.35% of Total Revenues.
- Per Share Earnings over the last 7 years have been positive in 2 years.
Vir Biotechnology Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Biotechnology |
| Sector: | Health Care |
| Current Symbol: | VIR |
| CUSIP: | 92764N |
| Website: | vir.bio |
Debt
| Debt-to-Equity Ratio: | 0 |
|---|---|
| Current Ratio: | 9.05 |
| Quick Ratio: | 8.68 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |
VIR Technical Analysis vs Fundamental Analysis
Buy
65
Vir Biotechnology (VIR)
is a Buy
Is Vir Biotechnology a Buy or a Sell?
-
Vir Biotechnology stock is rated a Buy
The current Vir Biotechnology [VIR] share price is $10.39. The Score for VIR is 65, which is 30% above its historic median score of 50, and infers lower risk than normal.